Pure Global

HbA1c Immunoturbidimetric Kit. Quantitative Determination of HbA1c by Immunoturbidimetric assay in Human Whole Blood - India CDSCO Medical Device Registration

HbA1c Immunoturbidimetric Kit. Quantitative Determination of HbA1c by Immunoturbidimetric assay in Human Whole Blood is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2020/000106_dccdc715f686a5ec1f3e1a11f40e5935_f6ad00aa0cbe5b0efe23d24253e2976c. This device is marketed under the brand name Qualax. The license holder is ADVY CHEMICAL PVT. LTD., and it is classified as Device Class Class B. The approving authority is Kokan Division.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
HbA1c Immunoturbidimetric Kit. Quantitative Determination of HbA1c by Immunoturbidimetric assay in Human Whole Blood
UID: MFG/IVD/2020/000106_dccdc715f686a5ec1f3e1a11f40e5935_f6ad00aa0cbe5b0efe23d24253e2976c

Brand Name

Qualax

Device Class

Class B

Approving Authority

Kokan Division

Product Information

HbA1c Immunoturbidimetric assay is intended for in vitro quantitative determination of HbA1c (Qualax) i.e. hemoglobin fraction by Immunoturbidimetric assay in Human Whole Blood.Percent HbA1c measurements are used for monitoring long-term glycemic control in diabetic patients

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing